BLACKROCK MULTI-SECTOR INCOME TRUST
BITDividend History
Investors can expect a dividend payout of $0.12 per share, scheduled to be distributed in 67 days on March 31, 2026
| Pay Date | Amount | Ex-Date | Record Date |
|---|---|---|---|
| March 31, 2026 | $0.12 | 2026-03-13 | 2026-03-13 |
| February 27, 2026 | $0.12 | 2026-02-13 | 2026-02-13 |
| January 30, 2026 | $0.12 | 2026-01-20 | 2026-01-20 |
| December 31, 2025 | $0.12 | 2025-12-22 | 2025-12-22 |
| November 28, 2025 | $0.12 | 2025-11-14 | 2025-11-14 |
Dividends Summary
- Consistent Payer: BLACKROCK MULTI-SECTOR INCOME TRUST has rewarded shareholders with 161 dividend payments over the past 13 years.
- Total Returned Value: Investors who held BIT shares during this period received a total of $19.57 per share in dividend income.
- Latest Payout: The most recent dividend of $0.12/share was paid 23 days ago, on December 31, 2025.
- Yield & Schedule: BIT currently pays dividends monthly with an annual yield of 11.21%.
- Dividend Growth: Since 2013, the dividend payout has grown by 6.0%, from $0.12 to $0.12.
- Dividend Reliability: BIT has maintained or increased its dividend for 99 consecutive payments.
Company News
ARGT, IWM, BIT, NVIDIA, Alibaba and JD.com are part of the Zacks Investment Ideas article.
We share updated data on over 100 big-yield opportunities, including CEFs, REITs, and MLPs. Learn more about PDI CEF and our recommendation.
Philogen enters into a Service and Supply Agreement with IBSA for the GMP Production of a Therapeutic Protein
The Phase II clinical trial investigates Philogen's immunocytokines (i) L19IL2 (ii) L19TNF, and (iii) Nidlegy™ in combination with MSD’s anti-PD-1 therapy, KEYTRUDA® (pembrolizumab) in stage III and IV unresectable melanoma patients who previously failed treatment with checkpoint inhibitors
Mumbai, India and Siena, Italy, 30th May 2023 – Sun Pharmaceutical Industries Limited (Reuters: SUN.BO, Bloomberg: SUNP IN, NSE: SUNPHARMA, BSE: 524715 (together with its subsidiaries and/or associated companies, “Sun Pharma”)) and Philogen S.p.A (BIT: PHIL) today announced that they have entered into a licensing agreement for commercializi...
